DiaSorin SpA
MIL:DIA

Watchlist Manager
DiaSorin SpA Logo
DiaSorin SpA
MIL:DIA
Watchlist
Price: 101.25 EUR 0.7% Market Closed
Market Cap: 5.5B EUR
Have any thoughts about
DiaSorin SpA?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
DiaSorin SpA

Revenue
1.2B EUR
Cost of Revenue
-408.6m EUR
Gross Profit
752.4m EUR
Operating Expenses
-506.5m EUR
Operating Income
246m EUR
Other Expenses
-78.2m EUR
Net Income
167.7m EUR

Margins Comparison
DiaSorin SpA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IT
DiaSorin SpA
MIL:DIA
5.4B EUR
65%
21%
14%
US
Abbott Laboratories
NYSE:ABT
205.7B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
184.5B USD
67%
26%
29%
US
Stryker Corp
NYSE:SYK
140.6B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
125.6B USD
69%
18%
11%
IE
Medtronic PLC
NYSE:MDT
114.7B USD
66%
19%
12%
US
Becton Dickinson and Co
NYSE:BDX
68.6B USD
45%
15%
7%
DE
Siemens Healthineers AG
XETRA:SHL
53.8B EUR
38%
12%
8%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.2B CNY
65%
37%
34%
US
Edwards Lifesciences Corp
NYSE:EW
40B USD
79%
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
40.2B USD
41%
13%
9%
Country IT
Market Cap 5.4B EUR
Gross Margin
65%
Operating Margin
21%
Net Margin
14%
Country US
Market Cap 205.7B USD
Gross Margin
56%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 184.5B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
29%
Country US
Market Cap 140.6B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 125.6B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
11%
Country IE
Market Cap 114.7B USD
Gross Margin
66%
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 68.6B USD
Gross Margin
45%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 53.8B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country CN
Market Cap 338.2B CNY
Gross Margin
65%
Operating Margin
37%
Net Margin
34%
Country US
Market Cap 40B USD
Gross Margin
79%
Operating Margin
28%
Net Margin
74%
Country US
Market Cap 40.2B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
9%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
DiaSorin SpA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IT
DiaSorin SpA
MIL:DIA
5.4B EUR
11%
5%
9%
7%
US
Abbott Laboratories
NYSE:ABT
205.7B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
184.5B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
140.6B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
125.6B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
114.7B USD
8%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
68.6B USD
5%
3%
6%
6%
DE
Siemens Healthineers AG
XETRA:SHL
53.8B EUR
11%
4%
8%
5%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.2B CNY
35%
23%
32%
40%
US
Edwards Lifesciences Corp
NYSE:EW
40B USD
59%
43%
19%
20%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
40.2B USD
22%
5%
10%
7%
Country IT
Market Cap 5.4B EUR
ROE
11%
ROA
5%
ROCE
9%
ROIC
7%
Country US
Market Cap 205.7B USD
ROE
15%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 184.5B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 140.6B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 125.6B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 114.7B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 68.6B USD
ROE
5%
ROA
3%
ROCE
6%
ROIC
6%
Country DE
Market Cap 53.8B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country CN
Market Cap 338.2B CNY
ROE
35%
ROA
23%
ROCE
32%
ROIC
40%
Country US
Market Cap 40B USD
ROE
59%
ROA
43%
ROCE
19%
ROIC
20%
Country US
Market Cap 40.2B USD
ROE
22%
ROA
5%
ROCE
10%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top